Atlas Trials

Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer

Clinical trial NCT03664869 · UNKNOWN

Trial details

NCT number
NCT03664869
Sponsor
Turku University Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2018-10-26
Primary completion
2025-11-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.